ENSG
The Ensign Group, Inc.NASDAQHealthcare$196.62-1.74%OpenMarket Cap: $11.43B
As of 2026-04-06
Valuation
P/E (TTM)
33.22
PEG
2.15
P/B
5.07
P/S
2.26
EV/EBITDA
26.55
DCF Value
$99.32
FCF Yield
3.2%
Div Yield
0.1%
Margins & Returns
Gross Margin
13.7%
Operating Margin
8.4%
Net Margin
6.8%
ROE
16.6%
ROA
6.4%
ROIC
6.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.36B | 8.7% | $123.8M | $95.5M | $1.61 | $0.13 |
| FY 2025 | $5.06B | 13.7% | $433.8M | $344.0M | $5.84 | $0.32 |
| Q3 2025 | $1.30B | 14.7% | $96.2M | $83.8M | $1.42 | $0.13 |
| Q2 2025 | $1.23B | 16.2% | $103.9M | $84.4M | $1.44 | $0.13 |
| Q1 2025 | $1.17B | 16.0% | $101.4M | $80.3M | $1.37 | $0.13 |
| Q4 2024 | $1.13B | 15.8% | $100.8M | $79.7M | $1.36 | $0.12 |
| FY 2024 | $4.26B | 15.7% | $358.3M | $298.0M | $5.12 | $0.30 |
| Q3 2024 | $1.08B | 15.4% | $89.3M | $78.4M | $1.34 | $0.12 |
| Q2 2024 | $1.04B | 15.7% | $86.0M | $71.0M | $1.22 | $0.12 |
| Q1 2024 | $1.01B | 15.7% | $82.2M | $68.8M | $1.19 | $0.12 |
| Q4 2023 | $980.4M | 15.2% | $22.8M | $21.7M | $0.38 | $0.12 |
| FY 2023 | $3.73B | 15.8% | $255.4M | $209.4M | $3.65 | $0.29 |